Across TCGA pan-cancer cohorts, RNU6-501P RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of RNU6-501P’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where RNU6-501P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RNU6-501P is over-expressed in tumor.

KIRC, LUAD, and STAD are the cancer types where RNU6-501P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RNU6-501P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	IV	+0.216	.017	5	view →
LUAD	All	All	+0.184	.037	3	view →
STAD	All	II,III,IV	+0.580	.019	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

Exploration

Same gene, other analysis: RNU6-501P RNA expression & survival · all RNU6-501P data types